PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
-0.69%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$195M
AUM Growth
+$195M
(-21%)
Cap. Flow
-$64.1M
Cap. Flow
% of AUM
-32.89%
Top 10 Holdings %
Top 10 Hldgs %
43.4%
Holding
99
New
20
Increased
12
Reduced
16
Closed
37
Top Buys
| 1 |
UnitedHealth
UNH
|
$10M |
| 2 |
AbbVie
ABBV
|
$9.42M |
| 3 |
Hologic
HOLX
|
$8.6M |
| 4 |
BCR
CR Bard Inc.
BCR
|
$8.2M |
| 5 |
iShares Europe ETF
IEV
|
$7.22M |
Top Sells
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
$10.5M |
| 2 |
Stryker
SYK
|
$9.82M |
| 3 |
Abbott
ABT
|
$8.67M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$8.13M |
| 5 |
Eli Lilly
LLY
|
$7.49M |
Sector Composition
| 1 | Healthcare | 73.65% |
| 2 | Industrials | 5.13% |
| 3 | Financials | 2.48% |
| 4 | Technology | 1.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UnitedHealth
UNH
$281B
| $10M | 3.67% | +62,500 | New | +$10M |
|
|
ATHN
2
DELISTED
Athenahealth, Inc.
ATHN
| $9.99M | 3.66% | 95,000 +40,000 | +73% | +$4.21M |
|
|
3
AbbVie
ABBV
$372B
| $9.42M | 3.45% | +150,375 | New | +$9.42M |
|
|
EVHC
4
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $8.97M | 3.29% | 141,644 -165,402 | -54% | -$10.5M |
|
|
5
Hologic
HOLX
$14.9B
| $8.6M | 3.15% | +214,425 | New | +$8.6M |
|
6
Boston Scientific
BSX
$156B
| $8.22M | 3.01% | 380,000 +180,000 | +90% | +$3.89M |
|
|
BCR
7
DELISTED
CR Bard Inc.
BCR
| $8.2M | 3.01% | +36,500 | New | +$8.2M |
|
|
8
iShares Europe ETF
IEV
$2.31B
| $7.22M | 2.65% | +186,000 | New | +$7.22M |
|
|
NUVA
9
DELISTED
NuVasive, Inc.
NUVA
| $7.07M | 2.59% | +105,000 | New | +$7.07M |
|
10
Humana
HUM
$36.5B
| $6.84M | 2.51% | +33,500 | New | +$6.84M |
|
|
NXTM
11
DELISTED
NxStage Medical Inc.
NXTM
| $6.75M | 2.47% | 257,500 -107,500 | -29% | -$2.82M |
|
12
Baxter International
BAX
$12.7B
| $6.65M | 2.44% | 150,000 -10,000 | -6% | -$443K |
|
13
Penumbra
PEN
$10.6B
| $6.06M | 2.22% | 95,000 +45,000 | +90% | +$2.87M |
|
14
Bio-Rad Laboratories Class A
BIO
$8.06B
| $5.56M | 2.04% | +30,500 | New | +$5.56M |
|
15
Globus Medical
GMED
$8.27B
| $4.96M | 1.82% | +200,000 | New | +$4.96M |
|
|
KTWO
16
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.85M | 1.78% | 242,200 -133,023 | -35% | -$2.67M |
|
|
AET
17
DELISTED
Aetna Inc
AET
| $4.84M | 1.77% | 39,000 -30,333 | -44% | -$3.76M |
|
|
CYNO
18
DELISTED
Cynosure, Inc. Class A
CYNO
| $4.56M | 1.67% | 100,000 +40,000 | +67% | +$1.82M |
|
19
Illumina
ILMN
$15.8B
| $4.48M | 1.64% | +35,000 | New | +$4.48M |
|
|
SIEN
20
DELISTED
Sientra, Inc.
SIEN
| $4.26M | 1.56% | 500,000 -52,664 | -10% | -$449K |
|
21
Glaukos
GKOS
$5.5B
| $3.77M | 1.38% | +109,903 | New | +$3.77M |
|
22
Medpace
MEDP
$13.4B
| $3.7M | 1.36% | 102,507 -55,921 | -35% | -$2.02M |
|
|
GWPH
23
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.6M | 1.32% | 32,250 +4,395 | +16% | +$491K |
|
|
NSTG
24
DELISTED
NanoString Technologies, Inc.
NSTG
| $3.6M | 1.32% | 161,311 +64,325 | +66% | +$1.43M |
|
|
NXGN
25
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.51M | 1.29% | +266,617 | New | +$3.51M |
|